Gliptin Therapy Improve Adiponectin Levels in T2DM Mets

• Main Authors: Jongky Hendro Prayitno, Askandar Tjokroprawiro, Sri Murtiwi, Agung Pranoto, Ari Sutjahjo, Soebagijo Adi Soelistijo, Sony Wibisono
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Elsevier BV 2014
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/108480/1/C-23.pdf; http://repository.unair.ac.id/108480/2/C-23%20kadep.pdf; http://repository.unair.ac.id/108480/3/C-23%20turnitin.pdf; http://repository.unair.ac.id/108480/; https://www.diabetesresearchclinicalpractice.com/action/showPdf?pii=S0168-8227%2814%2970483-8; https://doi.org/10.1016/S0168-8227(14)70483-8
• Institution: Universitas Airlangga

Background: Incretin released by cells in the small bowel in response to food intake, stimulate insulin release. The Incretin are significantly reduced in Type 2 Diabetes Mellitus (T2DM). This hormone have a variety of actions including the stimulation of insulin release from pancreatic beta cell. S...